• by admin
• (0) Comments

Morepen Labs wins ₹825 cr global CDMO deal

Morepen Laboratories has secured a major multi-year CDMO contract worth ~₹825 crore (USD 91 million) with a global pharmaceutical major — one of the largest in its history. Supplies are slated to begin within 4–5 months. (Express Pharma)

➡️ This puts India’s contract manufacturing capabilities in the spotlight and reinforces global confidence in domestic pharma quality systems.

Picture taken from Morepen website: https://www.morepen.com/

🔗 Source: https://www.expresspharma.in/amp/morepen-laboratories-secures-%E2%82%B9825-cr-cdmo-mandate-from-global-pharma-company/ (Express Pharma)

---

Boehringer Ingelheim & NIPER Raebareli sign pharma research MoU

Boehringer Ingelheim signed a collaborative MoU with National Institute of Pharmaceutical Education and Research to strengthen pharmaceutical education and research on novel drug delivery systems and technology platforms in India. (ETPharma.com)

🔗 Source: https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/boehringer-ingelheim-niper-raebareli-ink-mou-to-strengthen-pharmaceutical-education-and-research-collaboration/128665186 (ETPharma.com)

---

Brazil seeks deeper pharma cooperation with India

Brazil’s Health Ministry is looking to expand pharmaceutical partnerships with India — including local production of generics and tech transfer for medicines — during President Luiz Inácio Lula da Silva’s state visit. (Awaz The Voice)

🔗 Source: https://www.awazthevoice.in/world-news/brazil-seeks-pharma-partnership-with-india-52036.html (Awaz The Voice)

---

Himalaya appoints new leader for Healthcare & Pharma business

Himalaya Wellness Company elevated Vikas Bansi to head its Healthcare Business for the Pharma & OTC division — indicating strategic expansion and leadership realignment as the company seeks deeper market penetration. (exchange4media)

🔗 Source: https://www.exchange4media.com/people-movement-news/vikas-bansi-to-lead-himalayas-healthcare-business-for-pharma-and-otc-division-152267.html (exchange4media)

---

Biocon, BahiaFarma & Bionovis ink pharma MoU

Biocon Biologics joined Brazilian partners BahiaFarma & Bionovis in an MoU to co-develop key therapeutic ingredients, including for rare diseases and oncology medicines — signed at the India-Brazil business forum. (ETPharma.com)

🔗 Source: https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/bahiafarma-biocon-bionovis-inks-mou-in-pharma-sector/128695864 (ETPharma.com)